Mark Sheptoff Financial Planning’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7
| Closed | -$34 | – | 434 |
|
|
2024
Q2 | $34 | Hold |
7
| – | – | ﹤0.01% | 428 |
|
|
2024
Q1 | $56 | Hold |
7
| – | – | ﹤0.01% | 398 |
|
|
2023
Q4 | $27 | Hold |
7
| – | – | ﹤0.01% | 394 |
|
|
2023
Q3 | $20 | Hold |
7
| – | – | ﹤0.01% | 382 |
|
|
2023
Q2 | $206 | Hold |
7
| – | – | ﹤0.01% | 382 |
|
|
2023
Q1 | $330 | Hold |
7
| – | – | ﹤0.01% | 375 |
|
|
2022
Q4 | $164 | Hold |
7
| – | – | ﹤0.01% | 386 |
|
|
2022
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 365 |
|
|
2022
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 387 |
|
|
2022
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 431 |
|
|
2021
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 456 |
|
|
2021
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 393 |
|
|
2021
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 413 |
|
|
2021
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 377 |
|
|
2020
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 354 |
|
|
2020
Q3 | $2K | Hold |
7
| – | – | ﹤0.01% | 294 |
|
|
2020
Q2 | $1K | Hold |
7
| – | – | ﹤0.01% | 338 |
|
|
2020
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 342 |
|
|
2019
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 361 |
|
|
2019
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 356 |
|
|
2019
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 348 |
|
|
2019
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 351 |
|
|
2018
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 327 |
|
|
2018
Q3 | $0 | Buy |
+7
| New | – | ﹤0.01% | 360 |
|